Marksans Pharma Limited has informed the Exchange regarding a press release dated November 03, 2023, titled "Marksans Pharma Limited's wholly owned subsidiary Time-Cap Laboratories, Inc, receives Establishment Inspection Report from US FDA".
Marksans Pharma Limited has informed the Exchange regarding a press release dated November 03, 2023, titled "Marksans Pharma Limited's wholly owned subsidiary Time-Cap Laboratories, Inc, receives Establishment Inspection Report from US FDA".